首页> 外文会议>IEEE International Ultrasonics Symposium >Characterization of sentinel lymph nodes using dual-targeted microbubbles
【24h】

Characterization of sentinel lymph nodes using dual-targeted microbubbles

机译:双靶带微泡的哨落淋巴结表征

获取原文

摘要

The purpose of this ongoing study is to evaluate the ability of molecular ultrasound imaging to detect the metastatic involvement in the sentinel lymph node (SLN) of melanoma. The SLN is the first node along the lymphatic channel from the primary tumor and accurate characterization of the SLN helps in the clinical management of melanoma. To date, eight swine (3-7 kg; Sinclair BioResources, Columbia, MO, USA) with naturally occurring melanoma have been studied. Contrast enhanced ultrasound on a S3000 scanner with a 9L4 probe (Siemens Healthineers, Mountain View, CA, USA) was used for imaging. Dual-targeted microbubbles were created with Targestar SA (Targeson, San Diego, CA, USA) labeled with P-selectin and α_Vβ_3-integrin. IgG labeled Targestar SA was used as control. A two stage imaging approach was used to first identify and then characterize SLNs. First, 0.25 ml of Sonazoid (GE Healthcare, Oslo, Norway) was injected around the tumor and SLNs were identified. Next, dual-targeted and control microbubbles were injected IV with a 30 min interval between injections. Agents were allowed to circulate for 4 min to enable binding. Then 2 sets of image clips were collected before and after a high-power destruction sequence. The mean intensity difference in pre- and post- destruction images was calculated as a relative bubble retention measure. Some non-SLNs were also imaged in this fashion as control. All examined nodes were dissected and histologically examined for the presence of metastatic involvement. A total of 30 lymph nodes (16 SLNs and 14 non-SLNs) were analyzed with 10 SLNs showing metastatic involvement greater than 5%. All non-SLNs were benign. The mean intensity of the dual-targeted bubbles was significantly higher than that of IgG control bubbles in the metastatic SLNs (19.23 ± 23.95 AU vs. 0.20 ± 0.26 AU; p=0.03). Benign nodes did not show significant difference in the mean intensity of the dual-targeted and control bubbles (0.85 ± 1.81 AU vs. 0.03 ± 0.26 AU; p=0.07). Additionally, the mean intensity of dual-targeted bubbles for metastatic nodes was significantly different from that of benign nodes (p=0.002), while control bubbles did not differentiate between metastatic and benign nodes (p=0.09). The results indicate that dual-targeted microbubbles labeled with P-selectin and α_Vβ_3-integrin can help to characterize SLNs.
机译:该持续研究的目的是评估分子超声成像检测黑色素瘤的Sentinel淋巴结(SLN)中的转移累录的能力。 SLN是沿着淋巴通道的第一节点,来自原发性肿瘤,并准确表征SLN有助于黑色素瘤的临床管理。迄今为止,已经研究了八个猪(3-7公斤;辛克莱生物资源,哥伦比亚,Mo,USA),已经研究了天然存在的黑色素瘤。对比度增强超声波在S3000扫描仪上用9L4探头(西门子Healthineers,Cavie,CA,USA)用于成像。用Tarlustar SA(Targeraon,San Diego,CA,USA)与P-Selectin和α_Vβ_3-Integle in一起创建双靶点微泡。 IgG标记的Tarigalar SA被用作对照。使用两个阶段成像方法首先识别,然后表征SLN。首先,将0.25毫升Senazoid(GE Healthcare,OSLO,挪威)注入肿瘤周围,并确定了SLNS。接下来,在注射间隔30分钟内注射双靶向和控制微泡。允许试剂循环4分钟以便能够结合。然后在高功率破坏序列之前和之后收集2组图像剪辑。作为相对泡沫保留度量计算预拆动图像的平均强度差异。某些非SLNS也以这种方式对控制成像。对所有检查的节点进行解剖和组织学检查,用于存在转移性受累。分析了总共30个淋巴结(16个SLN和14个非SLNS),其中10个SLN显示大于5%的转移性受累。所有非SLNS都是良性的。双靶气泡的平均强度显着高于转移基板中的IgG对照气泡(19.23±23.95 Au与0.20±0.26 Au; P = 0.03)。良性节点在双靶点和控制气泡的平均强度没有显示出显着差异(0.85±1.81 AU与0.03±0.26 Au; P = 0.07)。另外,转移节点的双靶气泡的平均强度与良性节点的双重泡泡(P = 0.002)显着不同,而控制气泡没有区分转移和良性节点(P = 0.09)。结果表明,用p-selectin和α_vβ_3-整合蛋白标记的双靶标微泡可以有助于表征SLNS。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号